Search clinical trials for: Liraglutide Orlistat

Total 512 results

The First Affiliated Hospital of Xiamen University

Unknown

Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD) (LiraGooD)

Overweight and Obesity | Hyperglycaemia (Diabetic) | Type 2 Diabetes Patients

China
East Carolina University

Terminated

Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding

Type 2 Diabetes | Gastric Banding

United States
Novo Nordisk A/S

Completed

The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes

Obesity | Metabolism and Nutrition Disorder

Spain, Denmark, Sweden, Belgium, Finland, Netherlands, United Kingdom, Czechia
Marmara University

Recruiting

Life Style Modification Medical and Surgical Management in Patients With Obesity

Obesity | Obesity, Metabolically Benign | Weight Change, Body | Obesity; Endocrine

Turkey
Columbia University

Recruiting

Effects of GH and Lirglutide on AgRP

Healthy | Growth Hormone Deficiency

United States
GlaxoSmithKline

Completed

A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms

Overweight

United Kingdom
Shandong New Time Pharmaceutical Co., LTD

Completed

Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg

Bioequivalence

China
GlaxoSmithKline

Completed

Meta-analysis of Orlistat Laboratory Data From Placebo-controlled Clinical Trials

Obesity
Yazd Research & Clinical Center for Infertility
Yazd Medical University

Completed

Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients

Obesity

Iran, Islamic Republic of
University Medical Center Groningen
Erasmus Medical Center; De Najjar Stichting

Completed

Orlistat Treatment of Crigler-Najjar Disease

Crigler-Najjar Syndrome

Netherlands
Shanghai 10th People's Hospital

Completed

Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia

Uric Acid

China
Shionogi

Completed

Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

Obesity

United States
EMS

Completed

Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults

Obesity

Brazil
Certmedica International GmbH

Completed

RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity

Obesity | Overweight

Germany, Italy
Empros Pharma AB
CTC Clinical Trial Consultants AB

Active, not recruiting

Study Exploring the Supportive Effect of Acarbose in Weight Management

Overweight or Obesity

Sweden
Hoffmann-La Roche

Completed

A Study of Xenical (Orlistat) in Overweight and Obese Adolescents

Obesity

Russian Federation
National Institute of Diabetes and Digestive and...
Hoffmann-La Roche

Completed

Effectiveness of Brief Counseling for Weight Management

1. Obesity

United States
University of Texas Southwestern Medical Center

Terminated

Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia

Type 1 Hyperlipoproteinemia

United States
Jack Yanovski
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases

Hypertension | Obesity | Diabetes Mellitus | Metabolic Disease | Sleep Apnea Syndrome

United States
Woman's
Novo Nordisk A/S

Completed

Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS (SAXAPCOS)

Polycystic Ovary Syndrome | Pre Diabetes | Obesity Android

United States
St. Louis University
Hoffmann-La Roche

Completed

Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)

Hepatitis | Fatty Liver

United States
Sheffield Teaching Hospitals NHS Foundation Trust
Hoffmann-La Roche

Completed

An RCT of Metformin Vs Orlistat in Obese Anovulatory Women

Obesity | Anovulation

United Kingdom
Novo Nordisk A/S

Completed

Metabolism and Excretion of Liraglutide in Healthy Male Volunteers

Healthy | Diabetes

Netherlands
The Affiliated Hospital of Qingdao University

Completed

A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects

Therapeutic Equivalency

China
Merck Sharp & Dohme LLC

Completed

Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)

Type 2 Diabetes Mellitus
Sunshine Lake Pharma Co., Ltd.

Completed

A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects

Type 2 Diabetes

China
Henrik Gudbergsen

Completed

Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance (IM-LOSEIT-II)

Obesity | Osteoarthritis

Denmark
Parker Research Institute

Completed

Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis

Osteoarthritis, Knee

Denmark
Henrik Gudbergsen

Completed

Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance (BIO-LOSEIT-II)

Obesity | Osteoarthritis

Denmark
Jean Michel Hascoet
Chiesi Farmaceutici S.p.A.; ARAIRLOR

Completed

Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia (CURDYS)

Infant, Premature, Diseases | Respiratory Distress Syndrome, Newborn | Bronchopulmonary Dysplasia

France
Affiliated Hospital of Nantong University

Enrolling by invitation

Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM

T2D | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

China
Henrik Gudbergsen
Novo Nordisk A/S; Cambridge Weight Plan Limited

Completed

Liraglutide 3 mg for Knee Osteoarthritis (LOSEIT)

Obesity | Osteoarthritis

Denmark
Henrik Gudbergsen

Completed

Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance (US-LOSEIT-II)

Obesity | Osteoarthritis

Denmark
Fifth Affiliated Hospital of Xinjiang Medical University
West China Hospital

Unknown

Ezetimibe and Orlistat Affect the Intestinal Flora of Hyperlipidemia.

Hyperlipidemia
University Medical Centre Ljubljana

Completed

Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity

Obesity | Polycystic Ovary Syndrome

Slovenia
Stanford University
National Institute of Mental Health (NIMH)

Completed

Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder

Overweight | Eating Disorders

United States
University of Sao Paulo General Hospital
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Effects of Weight Loss in Obese Difficult-to-treat Asthmatics

Obesity | Asthma | Weight Loss

Brazil
Empros Pharma AB
CTC Clinical Trial Consultants AB

Completed

A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary)

Overweight or Obesity

Sweden
Chen Wei Ren, MD

Unknown

Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury

Acute Myocardial Infarction

China
Stanford University

Completed

Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood

Inflammation | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset

United States
Novo Nordisk A/S

Completed

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy (DUAL™ III)

Diabetes Mellitus, Type 2 | Diabetes

United States, Slovakia, Hungary, France, Australia
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care

Obesity | Binge Eating

United States
Novo Nordisk A/S

Completed

Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.

Obesity | Overweight

United States, United Kingdom, Canada, Denmark, Finland, Serbia, Poland, Japan, South Africa, Ireland
Novo Nordisk A/S

Completed

Comparison of Two Liraglutide Formulations in Healthy Volunteers

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

In-market Utilisation of Liraglutide Used for Weight Management in Europe

Obesity | Metabolism and Nutrition Disorder

Italy, Germany
Novo Nordisk A/S

Completed

A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.

Diabetes Mellitus, Type 2 | Diabetes

Japan
Novo Nordisk A/S

Completed

Comparison of Three Liraglutide Formulations in Healthy Volunteers

Healthy | Diabetes

Australia
Novo Nordisk A/S

Completed

Comparison of Two Liraglutide Formulations in Healthy Subjects

Healthy | Diabetes

Sweden
Novo Nordisk A/S

Completed

Bioequivalence of Two Liraglutide Formulations in Healthy Volunteers

Healthy | Diabetes

Sweden
Novo Nordisk A/S

Completed

Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes (ROOTS)

Diabetes Mellitus, Type 2 | Diabetes

Belgium

Search clinical trials for: Liraglutide Orlistat

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations